# V1 Empirics Check — moonshotai/kimi-k2.5 (Variant B)

**Model:** moonshotai/kimi-k2.5
**Variant:** B
**Date:** 2026-03-26T11:23:00.083401

---

**Referee Report**

**Manuscript:** "The Missing Cliff: SNAP Emergency Allotment Expiration and the Absence of an Acute Care Cascade"

**1. Idea Fidelity**

The paper pursues the core empirical question from the original manifest—whether SNAP Emergency Allotment (EA) expiration shifted Medicaid utilization toward emergency departments—using the proposed T-MSIS data and Callaway-Sant'Anna staggered difference-in-differences design. However, it significantly narrows the scope in ways that undermine the original contribution. The manifest emphasized novel analysis of **provider supply dynamics** (entry/exit rates, workload shifts, and the noted spike in provider exits from 4,400 to 8,100 monthly), proposed a **dosage** analysis exploiting state-specific benefit loss amounts, and suggested a **triple-difference** design using county-level SNAP participation rates. None of these appear in the current draft. The "smoke test" data on provider exits appears only as a descriptive statistic in the introduction, while Table 2 offers only a single underpowered coefficient on claims-per-provider without any extensive margin analysis. The paper has effectively transformed a study of Medicaid provider markets into a standard utilization composition analysis, missing the supply-side mechanisms that constituted the primary novelty claim.

**2. Summary**

Using a staggered difference-in-differences design across 18 early-terminating and 33 control states from 2018–2024, the paper finds precise null effects of SNAP EA expiration on the emergency department (ED) share of Medicaid utilization (ATT = –0.009, SE = 0.005). The results challenge the policy narrative that food benefit cuts mechanically increase acute care costs, suggesting that the hypothesized "acuity cascade" from nutritional shocks to ED presentations does not operate at detectable margins in administrative claims data.

**3. Essential Points**

1.  **Failure to deliver on provider market analysis.** The paper sets up expectations for analysis of provider supply responses—entry/exit rates, workload dynamics, and the spike in provider exits noted in the smoke test—but delivers only a single row in Table 2 on claims-per-provider. The extensive margin (provider entry/exit) is entirely absent despite being highlighted as "entirely unstudied" and central to the research design in the manifest. This creates a significant disconnect between the paper's framing (and title's invocation of "provider markets") and its actual contribution. If T-MSIS cannot support reliable entry/exit measurement, the paper should be reframed; if it can, these results must be presented.

2.  **Mechanistic ambiguity undermines interpretation.** The paper cannot distinguish between two competing explanations for the null: (a) EA expiration did not materially worsen food security or health (the mechanism failed), or (b) health deteriorated but patients did not seek ED care (the mechanism shifted to non-utilization, uninsured status, or mortality). The "missing patient" hypothesis—whereby the most vulnerable enrollees lost Medicaid coverage entirely—is mentioned but not tested. Without data on intermediate outcomes (food insufficiency indices, HbA1c levels, or at least Medicaid enrollment retention) or analysis of uninsured ED visits, the finding is difficult to interpret for policy. The paper risks concluding "no cascade" when the cascade may have flowed out of the Medicaid program entirely.

3.  **Control group contamination from Medicaid unwinding.** The identification strategy relies on "never-treated" states (through February 2023) as controls for early terminators (2021–2022). However, the Medicaid unwinding beginning April 2023 disproportionately affected these "control" states, which had maintained continuous enrollment until that point. If the unwinding induced utilization changes or coverage erosion in the control group, the parallel trends assumption fails. The paper notes this threat but does not convincingly address it—truncating the sample at March 2023 or explicitly comparing early (2021) versus late (2023) terminators would provide cleaner identification.

**4. Suggestions**

*Reframing and Scope*

If the provider dynamics data prove infeasible (e.g., if NPPES geocoding cannot reliably track entry/exit at the state-month level), remove the "provider markets" framing from the title and introduction. The current title ("...and the Absence of an Acute Care Cascade") is accurate, but the setup promises supply-side analysis that never arrives. Alternatively, if the smoke test data on provider exits (4,400 to 8,100 monthly) are real and attributable to the policy, this is a massive result that deserves formal modeling—perhaps as a separate outcome equation. The current treatment of this as a passing observation wastes the paper's most policy-relevant finding.

*Strengthening Mechanistic Claims*

The paper should formally incorporate the \citet{east2024snap} food insufficiency results as a "first stage" check. If East shows food insecurity *did* increase in these same states while you show ED utilization did not, this strengthens the interpretation that the health-production function decoupled, not that the policy had no effect. Consider bounding the possible cascade using the method of \citet{machado2019testing} to ask: "Given the observed increase in food insecurity, what elasticity of ED utilization would be required to produce the observed null, and is that elasticity plausible?" This would transform the null from a "non-finding" into a precise structural statement about health behavior.

*Addressing the Unwinding and Sample Selection*

I strongly recommend reporting main results truncated at March 2023 (pre-unwinding) as the primary specification. The current sample runs through December 2024, but the control group is compromised after April 2023. You can demonstrate robustness by showing that results are similar when using only the 2021 early terminators versus the 2022–2023 cohorts, leveraging the fact that the 2021 cohorts provide clean variation pre-dating both the unwinding and the COVID recovery period. Additionally, test for differential Medicaid enrollment trends between treatment and control groups; if enrollment fell differentially in early-terminating states (the "missing patient" hypothesis), your null result on utilization *per enrollee* may mask a true increase *per capita* among remaining enrollees.

*Dosage and Heterogeneity*

The original manifest proposed exploiting dosage variation (state SNAP participation rate × EA loss amount). This would add power and credibility by moving beyond a binary treatment to capture the intensity of the benefit shock. Even a simple interaction between the EA expiration indicator and the state's pre-pandemic SNAP participation rate would strengthen the design. Similarly, the triple-difference using within-state county variation (counties with high SNAP penetration vs. low) would address concerns about unobserved state-level confounders correlated with Republican governance.

*External Validity and Cost Calculations*

The abstract notes that the fiscal arithmetic of SNAP cuts changes if the "penny wise, pound foolish" argument fails. Calculate this explicitly: using your confidence intervals, construct the upper bound on avoided ED costs per dollar of SNAP cut. With ED visits costing roughly $1,500 and primary care $150, your 95% CI upper bound of 0.002 percentage points implies maximum "false economy" savings of approximately $X million nationally—likely trivial against the budgetary savings from benefit reduction. This quantification would make the policy relevance concrete.

*Data Presentation*

Table 1 shows remarkably similar baseline ED shares (28.3% vs. 28.6%), which supports the parallel trends assumption. However, the early-terminating states appear much smaller (mean ED claims of 69,919 vs. 114,098). Verify that results are robust to population weighting or including state population as a covariate. Also, clarify the behavioral health placebo: if SNAP affects mental health through nutritional pathways (e.g., serotonin precursors), the placebo may be "contaminated." A better placebo might be dental codes or other non-acute services less plausibly linked to food insecurity.

*Minor Issues*

The paper cites 33 states plus D.C. as controls in some places and 32 plus D.C. in others; reconcile this. The standardized effect size table in the appendix is helpful but should be referenced in the main text. Finally, the autonomous generation disclosure is noted; ensure all data handling and de-identification protocols for T-MSIS meet CMS privacy requirements, as this may raise additional scrutiny during review.
